We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 278 results
  1. The association between serum ferritin levels and malignant intraductal papillary mucinous neoplasms

    Background

    Serum ferritin levels are elevated in many malignancies. In this study, we showed the performance of serum ferritin in identifying...

    **aoling Zhuge, Hao Zhou, ... Chuangen Guo in BMC Cancer
    Article Open access 20 November 2021
  2. Optimal surveillance of intraductal papillary mucinous neoplasms of the pancreas focusing on remnant pancreas recurrence after surgical resection

    Background

    The international consensus guidelines for intraductal papillary mucinous neoplasm of the pancreas (IPMN) presented clinical features as...

    Tomokazu Fuji, Yuzo Umeda, ... Toshiyoshi Fujiwara in BMC Cancer
    Article Open access 29 May 2022
  3. The application of single-cell sequencing in pancreatic neoplasm: analysis, diagnosis and treatment

    Pancreatic neoplasms, including pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) and pancreatic cystic...

    Gaoyuan Lv, Liang Zhang, ... Qiushi Tang in British Journal of Cancer
    Article 28 October 2022
  4. Hepatocellular carcinoma and solid pseudopapillary neoplasm of the pancreas complicating familial adenomatous polyposis: two cases and review of the literature

    Familial adenomatous polyposis (FAP) is characterized by colorectal polyposis and extracolonic tumors. Adenocarcinoma of the pancreas and...

    Jessica El Halabi, Lisa LaGuardia, ... Carol A. Burke in Familial Cancer
    Article 28 July 2022
  5. Classification prediction of pancreatic cystic neoplasms based on radiomics deep learning models

    Background

    Preoperative prediction of pancreatic cystic neoplasm (PCN) differentiation has significant value for the implementation of personalized...

    Wenjie Liang, Wuwei Tian, ... Xueli Bai in BMC Cancer
    Article Open access 29 November 2022
  6. Develop Nomogram to Predict Malignancy of Intraductal Papillary Mucinous Neoplasm

    A nomogram is a useful graphical tool for presenting a risk prediction and prognosis prediction in medical research. Intraductal papillary mucinous...
    Yongkang Kim, Taesung Park in Pancreatic Cancer
    Protocol 2019
  7. Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis

    Background

    Intraductal papillary neoplasms (IPN) and biliary epithelial neoplasia (BilIN) are well‐defined precursor lesions of biliary tract...

    Alphonse Charbel, Luca Tavernar, ... Benjamin Goeppert in British Journal of Cancer
    Article Open access 06 September 2022
  8. Precursor lesions in familial and hereditary pancreatic cancer

    Infiltrating ductal adenocarcinoma of the pancreas, referred to here as “pancreatic cancer,” is one of the deadliest of all of the solid...

    Michael J. Pflüger, Lodewijk A.A. Brosens, Ralph H. Hruban in Familial Cancer
    Article 06 February 2024
  9. Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer

    Background

    Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease. This is due to its aggressive course, late diagnosis and its intrinsic drugs...

    Antonio Agostini, Ilaria Guerriero, ... Carmine Carbone in Journal of Translational Medicine
    Article Open access 23 November 2023
  10. Histopathological Characteristics: Breast Cancer Subtypes Depending on Receptor Status, Clinical and Pathological Staging of Breast Cancer

    Breast cancer (BC) is a clinically heterogeneous disease affecting around 14% female population worldwide with unique histopathological and...
    Pratibha Thakur, Kirti Baraskar, Vinoy K. Shrivastava in Breast Cancer: From Bench to Personalized Medicine
    Chapter 2022
  11. Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer

    Background

    First identified in Drosophila melanogaster , the Hippo pathway is considered a major regulatory cascade controlling tissue homeostasis and...

    Giulia Schiavoni, Beatrice Messina, ... Marcello Maugeri-Saccà in Journal of Translational Medicine
    Article Open access 29 February 2024
  12. The role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individuals

    Individuals at high risk of develo** pancreatic ductal adenocarcinoma are eligible for surveillance within research programs. These programs employ...

    Kasper A. Overbeek, Djuna L. Cahen, Marco J. Bruno in Familial Cancer
    Article Open access 04 April 2024
  13. Surgical aspects related to hereditary pancreatic cancer

    The goal of surveillance programs for individuals at risk (IAR) from familial pancreatic cancer (FPC) families or families with other inherited tumor...

    Elisabeth Maurer, Detlef K. Bartsch in Familial Cancer
    Article Open access 25 April 2024
  14. Experimental Model for Pancreatic Cancer and Its Therapeutic Implications in Clinical Research

    This book chapter aims to provide an overview knowledge on different animal models that has wide range of research implications in pancreatic cancer...
    Selvaraj Jayaraman, Bhuvaneswari Ponnusamy, ... Kirubhanand Chandrasekar in Handbook of Animal Models and its Uses in Cancer Research
    Reference work entry 2023
  15. Familial pancreatic cancer: a long fruitful journey

    In the early years of my GI fellowship, a healthy 40-year-old man came to my clinic and announced that he was going to die of pancreatic cancer. His...

    Teresa A Brentnall in Familial Cancer
    Article 04 March 2024
  16. Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential

    Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers worldwide, mainly due to its late diagnosis and lack of effective...

    Emilia Alors-Pérez, Sergio Pedraza-Arevalo, ... Justo P. Castaño in Journal of Experimental & Clinical Cancer Research
    Article Open access 26 October 2023
  17. Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer

    Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related deaths and is associated with a poor prognosis. The majority of these...

    Aleksander M. Bogdanski, Jeanin E. van Hooft, ... Monique E. van Leerdam in Familial Cancer
    Article Open access 15 April 2024
  18. Histopathological and Molecular Markers in the Assessment of Prostate Cancer Aggressivity

    Prostate cancer (PCa) in most patients does not cause significant clinical symptoms, but high-risk disease, accounting for approximately 15% of PCa,...
    Ljubinka Jankovic Velickovic in Prostate Cancer
    Chapter 2024
  19. Characteristics of familial pancreatic cancer families with additional colorectal carcinoma

    Familial pancreatic cancer (FPC) is a rare hereditary tumor entity with broad phenotypic heterogeneity, including colorectal carcinoma (CRC) in some...

    Bettina Lehman, Elvira Matthäi, ... Detlef K. Bartsch in Familial Cancer
    Article Open access 31 January 2023
  20. Preoperative profiles of plasma amino acids and derivatives distinguish periampullary cancer and benign disease

    Periampullary cancers, including pancreatic ductal adenocarcinoma, ampullary-, cholangio-, and duodenal carcinoma, are frequently diagnosed in an...

    Stina Margrethe Stålberg, Laxmi Silwal-Pandit, ... Elin Hegland Kure in BMC Cancer
    Article Open access 03 May 2024
Did you find what you were looking for? Share feedback.